Virtual wards and hospital at home show no survival or readmission benefit for ECOPD patients compared to hospital admission.
This systematic review and meta-analysis examined the safety and efficacy of virtual wards (VW) and hospital at home (HaH) care pathways compared to standard hospital admission for adults with exacerbations of chronic obstructive pulmonary disease (ECOPD). The analysis included data from 11 studies, with one assessing VWs and ten assessing HaH, conducted in hospital or patient home settings. The primary outcomes assessed were safety, specifically mortality rates at all causes, in-patient, 7 days, and 30 days, as well as readmission rates at 7 and 30 days. Secondary outcomes included length of stay in hospital and changes in pulmonary function tests.
Regarding primary outcomes, the meta-analysis found no changes in survival attributable to the interventions. Similarly, there were no changes in short-term readmission rates. Furthermore, there was no evidence that VW or HaH care pathways reduced the total time a patient spent under hospital-led care. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported in the included studies.
The authors note that more evidence is needed to support the widespread roll-out of HaH and especially VW pathways for ECOPD. Consequently, clinicians should interpret these findings with caution, recognizing that current data does not demonstrate a reduction in hospital time or improvement in survival or readmission metrics for this specific population.